Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
Qualigen Therapeutics, Inc. (QLGN)
Company Research
Source: GlobeNewswire
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasdaq indicating that the Nasdaq Hearings Panel (“Panel”) has granted an extension for the continued listing of the Company, subject to the Company evidencing compliance with all applicable criteria for continued listing on The Nasdaq Capital Market by November 19, 2024. The Company is diligently working to fulfill the requirements set forth by the Panel to ensure the Company’s continued listing on Nasdaq. About Qualigen Therapeutics, Inc. For more information about Qualigen Therapeutics, Inc., please visit www.qlgntx.com. Forward-Looking Statements This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company may in some cases use terms such
Show less
Read more
Impact Snapshot
Event Time:
QLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QLGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QLGN alerts
High impacting Qualigen Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
QLGN
News
- Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares [Yahoo! Finance]Yahoo! Finance
- Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred SharesGlobeNewswire
- Qualigen Therapeutics announces management changes Sep. 26, 2024 5:28 PM ET By: Akanksha Khushi , SA News Editor [Seeking Alpha]Seeking Alpha
- Qualigen Therapeutics, Inc. Announces management changes. [Yahoo! Finance]Yahoo! Finance
- Qualigen Therapeutics, Inc. Announces management changes.GlobeNewswire
QLGN
Sec Filings
- 11/21/24 - Form 8-K/A
- 11/21/24 - Form 8-K
- 11/15/24 - Form 3
- QLGN's page on the SEC website